Physician profile
Kevin Formes
NPI 1497878474
$6,731.56
in general payments reported to CMS, 2019-2025
32 companies · $212 in 2025
The $212 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,348 · 2020: $950 · 2021: $1,251 · 2022: $1,486 · 2023: $946 · 2024: $540 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,697.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $919.74 | 2019-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $802.43 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $686.79 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $592.19 | 2021-2024 | Verquvo |
| Baxter Healthcare | $506.11 | 2022 | |
| Pfizer INC. | $437.32 | 2019-2024 | |
| Amgen INC. | $358.36 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $295.62 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $292.19 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $233.36 | 2019-2022 | |
| Boston Scientific Corporation | $230.54 | 2019-2024 | Vigilant X4 Crt-D, Lux-Dx Insertable Cardiac Monitor |
| Abiomed | $192.55 | 2019-2025 | Impella |
| Shockwave Medical, INC | $144.66 | 2025 | |
| Alnylam Pharmaceuticals INC. | $137.50 | 2021-2023 | Onpattro |
| Amarin Pharma, INC. | $135.74 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $112.41 | 2022-2023 | Onyx Frontier |
| Abbott Laboratories | $93.01 | 2019-2023 | Mitraclip |
| Irhythm Technologies, INC. | $82.65 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Astellas Pharma US INC | $75.00 | 2019 | |
| Sanofi-Aventis U.S. LLC | $70.78 | 2019-2021 | |
| Esperion Therapeutics, INC. | $60.37 | 2020-2021 | |
| Gilead Sciences, INC. | $54.41 | 2019 | |
| Biotronik INC. | $35.81 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $32.72 | 2019 | |
| Bardy Diagnostics, INC. | $29.00 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $21.68 | 2024 | Uptravi, Opsumit |
| Medicomp INC | $21.05 | 2023 | Telepatch Cardiac Monitor |
| Qorumpartners | $19.36 | 2022 | |
| Cardiovascular Systems INC. | $16.36 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $15.31 | 2024 | |
| Arbor Pharmaceuticals, INC. | $14.21 | 2021 | |
| Terumo Medical Corporation | $12.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Formes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.